Zobrazeno 1 - 10
of 39
pro vyhledávání: '"TOSHIYUKI TAHARA"'
Publikováno v:
Life, Vol 13, Iss 6, p 1327 (2023)
Background: Both pemafibrate and sodium glucose cotransporter-2 (SGLT2) inhibitor can decrease serum transaminase levels in patients with non-alcoholic fatty liver disease (NAFLD) complicated with dyslipidemia and type 2 diabetes mellitus (T2DM), res
Externí odkaz:
https://doaj.org/article/4b880ff6a27e4fe8a5c4bd9fb1fefe96
Autor:
Naoteru Miyata, Katsura Emoto, Yoshiaki Dei, Kazuhiro Tomiyasu, Ryoko Ishiyama, Tomofumi Horie, Gen Sakai, Toshiyuki Tahara
Publikováno v:
Case Reports in Oncology, Vol 9, Iss 3, Pp 547-553 (2016)
Background: Dermatomyositis (DM) is an autoimmune disease characterized by cutaneous Gottron papules, heliotrope rash, and proximal myopathy. It may also present as a paraneoplastic syndrome that can complicate a variety of different cancers, such as
Externí odkaz:
https://doaj.org/article/f440340dcdd341599f2d75d370f03be5
Autor:
Satoshi Shinozaki1,2 shinozaki-s@aqua.ocn.ne.jp, Toshiyuki Tahara3, Kouichi Miura2, Alan Kawarai Lefor4, Hironori Yamamoto2
Publikováno v:
Clinical & Experimental Hepatology. 2022, Vol. 8 Issue 4, p278-283. 6p.
Publikováno v:
Life; Volume 13; Issue 6; Pages: 1327
Background: Both pemafibrate and sodium glucose cotransporter-2 (SGLT2) inhibitor can decrease serum transaminase levels in patients with non-alcoholic fatty liver disease (NAFLD) complicated with dyslipidemia and type 2 diabetes mellitus (T2DM), res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::03e2fb6f5bbc650ec96210688cb47cde
Autor:
Satoshi Shinozaki1,2 shinozaki-s@aqua.ocn.ne.jp, Toshiyuki Tahara3, Lefor, Alan Kawarai4, Ogura, Masahito5
Publikováno v:
Clinical & Experimental Hepatology. 2021, Vol. 7 Issue 2, p172-177. 6p.
Publikováno v:
Clinical and Experimental Hepatology
Aim of the study To optimize the long-term outcomes of patients with non-alcoholic fatty liver disease (NAFLD), long-term therapy is important to prevent cirrhosis and hepatocellular carcinoma. Pemafibrate, a novel selective peroxisome proliferator-a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d72dcd276df7fb0d8550a2374b9c158c
https://doi.org/10.5114/ceh.2021.106864
https://doi.org/10.5114/ceh.2021.106864
Autor:
Hirotaka Arai, Atsushi Naganuma, Takeshi Nihei, Tadashi Ikegami, Hidekazu Kurata, Takaaki Ohtake, Toshiyuki Tahara, Kouichi Miura, Katsuhiko Horiuchi, Ken Sato, Satoru Kakizaki, Shigeo Tano, Toshiro Kamoshida, Norio Isoda, Yukimura Fukaya, Atsuko Soeda, Makoto Iijima, Toshiya Ohtake, Takeharu Asano, Takeshi Hatanaka, Masashi Namikawa, Takeshi Fujieda, Naoki Morimoto, Shunji Watanabe, Takashi Ueno, Takashi Kosone, Toshimitsu Murohisa, Hironori Yamamoto, Yoshinari Takaoka
Publikováno v:
Hepatology Research. 51:51-61
AIM This study aimed to evaluate the real-world efficacy and safety of 12-week sofosbuvir/velpatasvir (SOF/VEL) treatment for patients with decompensated liver cirrhosis caused by hepatitis C virus (HCV) infection. METHODS A total 72 of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52903f616f3d14fcea8b2194824f38e5
https://doi.org/10.1111/hepr.13576
https://doi.org/10.1111/hepr.13576
Publikováno v:
The Journal of Medical Investigation. 67:280-284
The long-term outcomes of patients with non-alcoholic fatty liver disease (NAFLD) treated with sodium-glucose cotransporter-2 inhibitors remain indeterminate. Empagliflozin improves hyperglycemia by increasing glucose excretion in the urine, and it r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d68681dccb4ae878111d4915ee1c25c9
https://doi.org/10.2152/jmi.67.280
https://doi.org/10.2152/jmi.67.280
Autor:
Shunji Watanabe, Atsushi Naganuma, Tadashi Ikegami, Rie Goka, Hiroaki Nomoto, Takaaki Ohtake, Yoshinari Takaoka, Hirotaka Arai, Naoto Sato, Masashi Namikawa, Takashi Ueno, Toshiro Kamoshida, Hiroshi Maeda, Mamiko Tsukui, Norio Isoda, Hironori Yamamoto, Shigeo Tano, Takashi Kosone, Yukimura Fukaya, Takuya Hirosawa, Satoru Kakizaki, Kouichi Miura, Naoki Morimoto, Katsuhiko Horiuchi, Takeharu Asano, Takeshi Hatanaka, Toshimitsu Murohisa, Toshiyuki Tahara
Publikováno v:
Kanzo. 61:276-278
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::66aa0afcadaa99ba263bda6d12bb9a69
https://doi.org/10.2957/kanzo.61.276
https://doi.org/10.2957/kanzo.61.276
Autor:
Kimihiko Yangita, Takeshi Okanoue, Masayuki Tatemichi, Ichiro Kawana, Toshiyuki Tahara, Shinsuke Funakoshi, Yutaka Horie, Atsushi Nakazawa, Kazuhide Yamamoto, Kazuo Notsumata, Nobuhiro Tsukada, Masaki Oomoto, Tomoo Nagano, Toshihide Shima, Toru Ishikawa, Masanori Kawaguchi, Shinichi Fujioka, Hiroyuki Itoh
Publikováno v:
World Academy of Sciences Journal. 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f9cfe1b47a6beff000ab24a868604ee
https://doi.org/10.3892/wasj.2021.98
https://doi.org/10.3892/wasj.2021.98